TCL1A and Buschke-Ollendorff syndrome: Because POU2AF1, TCL1A, and BLK were differentially expressed in the PRED, that is, more than 6 months before the clinical diagnosis of BOS, we evaluated the predictive performance of these three markers using ROC curve analysis.